Gimoti (metoclopramide intranasal) / Evoke Pharma  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gimoti (metoclopramide intranasal) / Evoke Pharma
NCT02025725: Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis

Completed
3
205
US
Metoclopramide Nasal Spray, EVK-001, Placebo Nasal Spray, EVK-001 Placebo
Evoke Pharma
Diabetic Gastroparesis
05/16
06/16
NCT02025751: Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

Completed
3
53
US
Metoclopramide Nasal Spray, Placebo Nasal Spray, Vehicle
Evoke Pharma
Diabetic Gastroparesis
08/16
10/16

Download Options